Ledger.Open graph →
SEC Form D · filed February 14, 2020

Front Range Biosciences, Inc

Offering
$40.3M
Sold
$18.7M
Exemption
Rule 506(b)
Industry
Other
Location
LAFAYETTE, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

William Militello · Lafayette, CODirectorMarc Riiska · New York, NYDirectorNick Hofmeister · San Marcos, CAExec · DirectorJonathan Vaught · Lafayette, COExec · DirectorEphraim Lindenbaum · Campbell, CADirectorNick Hofmeister · San Marcos, CAExec · DirectorWilliam Militello · LAFAYETTE, CODirectorJonathan Vaught · Lafayette, COExec · DirectorMarc Riiska · New York, NYDirectorEphraim Lindenbaum · Aurora, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗